Posts Tagged ‘Reuters’
Friday, June 25th, 2010

Walgreen profit weaker than expected
by Ben Klayman
For more information go to www.reuters.com.
The information contained in this article represents SCM’s opinions, and should not be construed as personalized or individualized investment advice. Past performance is no guarantee of future results. The securities identified and described in this article do not represent all of the securities purchased or recommended for our clients. It should not be assumed that investing in these securities was or will be profitable. A list of all recommendations made by Smead Capital Management with in the past twelve month period is available upon request.
Tags: ben klayman, Bill Smead, Reuters, Walgreens
Posted in Press | No Comments »
Friday, April 16th, 2010

Cheap health stocks seen outpacing other sectors
by Lewis Krauskopf
For more information go to www.reuters.com.
The information contained in this article represents SCM’s opinions, and should not be construed as personalized or individualized investment advice. Past performance is no guarantee of future results. The securities identified and described in this article do not represent all of the securities purchased or recommended for our clients. It should not be assumed that investing in these securities was or will be profitable. A list of all recommendations made by Smead Capital Management with in the past twelve month period is available upon request.
Tags: Bill Smead, Lewis Krauskopf, Pharmaceuticals, Reuters
Posted in Press | No Comments »
Wednesday, February 17th, 2010

Walgreen to buy Duane Reade in New York expansion
by Phil Wahba
For more information go to www.reuters.com.
The information contained in this article represents SCM’s opinions, and should not be construed as personalized or individualized investment advice. Past performance is no guarantee of future results. The securities identified and described in this article do not represent all of the securities purchased or recommended for our clients. It should not be assumed that investing in these securities was or will be profitable. A list of all recommendations made by Smead Capital Management with in the past twelve month period is available upon request.
Tags: Bill Smead, Phil Wahba, Reuters, Walgreens
Posted in Press | No Comments »
Thursday, January 14th, 2010

ANALYSIS-Microsoft lacks wow at CES. Do investors care?
by Bill Rigby
For more information go to www.reuters.com.
The information contained in this article represents SCM’s opinions, and should not be construed as personalized or individualized investment advice. Past performance is no guarantee of future results. The securities identified and described in this article do not represent all of the securities purchased or recommended for our clients. It should not be assumed that investing in these securities was or will be profitable. A list of all recommendations made by Smead Capital Management with in the past twelve month period is available upon request.
Tags: Bill Rigby, Reuters
Posted in Press | No Comments »
Thursday, October 29th, 2009

Mylan 3rd-qtr results top estimates; shares rise
by Toni Clarke
For more information go to www.reuters.com.
The information contained in this article represents SCM’s opinions, and should not be construed as personalized or individualized investment advice. Past performance is no guarantee of future results. The securities identified and described in this article do not represent all of the securities purchased or recommended for our clients. It should not be assumed that investing in these securities was or will be profitable. A list of all recommendations made by Smead Capital Management with in the past twelve month period is available upon request.
Tags: Bill Smead, Reuters, Toni Clarke
Posted in Press | No Comments »